HP Inc. announced on February 21, 2025, the Board of Directors of the company expanded the size of the Board and elected Gianluca Pettiti to serve as a director of the Company. Mr. Pettiti is Executive Vice President and President, Life Sciences, Diagnostics and Applied at Thermo Fisher Scientific Inc. The Board has determined that Mr. Pettiti qualifies as an independent director under the listing standards of the New York Stock Exchange and the director independence standards set out in the Company?s Corporate Governance Guidelines. On February 21, 2025, the Board also appointed Mr. Pettiti to the Finance, Investment and Technology Committee and HR and Compensation Committee.
Mr. Pettiti is deeply committed to advancing the applications of technology across the industry and serves as a board member at the Italian Institute of Technology, a leading research institute in robotics and AI. Mr. Pettiti holds a Master of Science in Engineering from Politecnico di Torino, which recognized him as an Alumnus Testimonial in 2017 for his contributions to innovation. He has also authored several influential articles on AI and digital transformation in healthcare.
